NCT06326879 A Comparative Study Between Early Onset Colorectal Cancer and Late Onset Colorectal Cancer Patients
| NCT ID | NCT06326879 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istituto Clinico Humanitas |
| Condition | Colorectal Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 340 participants |
| Start Date | 2023-11-30 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 340 participants in total. It began in 2023-11-30 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to investigate the clinical, socioeconomic, behavioral, genetic, and molecular factors characterizing Early Onset Colorectal Cancer (EOCRC) patients compared with Late Onset Colorectal Cancer (LOCRC) patients
Eligibility Criteria
Inclusion Criteria: * Patients aged more than 18 years old at the time of inclusion. * Patients with a proven diagnosis of colorectal adenocarcinoma, as reported by the staging histological biopsies. * Patients with a preoperative staging I-III. * Patients scheduled for elective curative colorectal resection. * Patients with rectal cancer who underwent neoadjuvant therapy can be included in the study. * Patients able and willing to comply with the protocol requirements (samples' collection and questionnaires' compilation). Exclusion Criteria: * Patients with metastatic disease at diagnosis. * Patients requiring an emergent procedure. * Patients undergoing palliative surgery (for example, fecal diversion). * Patients with a surgical indication for benign lesions (for example, adenoma or dysplasia). * Patients with an intraoperative finding of a lesion other than adenocarcinoma will be withdrawn from the study. * Patients with an intraoperative finding of distal metastasis or peritoneal carcinosis will be withdrawn from the study. * Patients with a concomitant diagnosis of Inflammatory Bowel Disease. * Patients with a known genetic syndrome (for example, Lynch syndrome or Familial Adenomatous Polyposis).
Contact & Investigator
Antonino Spinelli, MD, PhD
PRINCIPAL INVESTIGATOR
IRCCS Huamanitas Research Hospital
Frequently Asked Questions
Who can join the NCT06326879 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06326879 currently recruiting?
Yes, NCT06326879 is actively recruiting participants. Contact the research team at colorapp@humanitas.it for enrollment information.
Where is the NCT06326879 trial being conducted?
This trial is being conducted at Rozzano, Italy.
Who is sponsoring the NCT06326879 clinical trial?
NCT06326879 is sponsored by Istituto Clinico Humanitas. The principal investigator is Antonino Spinelli, MD, PhD at IRCCS Huamanitas Research Hospital. The trial plans to enroll 340 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.